JAK2 and neoplasm: Secondary alterations affecting cytokine signalling occurred in 37% iAMP21 of tumours (QBinomial = 2.2 × 10−3) involving IL7R, JAK2 or CRLF2 (including 3/5 cases of P2RY8-CRLF2 translocation).